Zentalis Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ZNTL on Nasdaq
Industry
Pharmaceutical Preparations
Location
10275 Science Center Drive, Suite 200, San Diego, California

Insiders trading volume in the past year

Zentalis Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matrix Capital Management Company, LP 10%+ Owner $144M Jun 20, 2023
Anthony Y. Sun President & CEO, Director $26.7M Apr 4, 2022
Iris Roth Chief Operating Officer $14.8M Mar 1, 2023
Kevin D. Bunker Chief Scientific Officer $8.75M -$118K -1.33% Dec 20, 2023
Cam Gallagher President, Interim CFO, Director $7.59M -$262K -3.33% May 31, 2024
Kimberly Blackwell Chief Executive Officer, Director $5.66M +$51.4K +0.92% Feb 1, 2024
Melissa Epperly Chief Financial Officer $5.16M -$236K -4.38% Feb 12, 2024
Diana Hausman Chief Medical Officer $4.72M -$42.4K -0.89% May 9, 2024
David M. Johnson Director $2.31M +$168K +7.84% Jun 21, 2024
Mark Lackner Chief Scientific Officer $2.26M -$18.3K -0.8% Feb 1, 2024
Alexis Pinto Chief Legal Officer $2.07M Feb 10, 2022
Andrea Paul Chief Legal Officer $1.73M -$38.2K -2.16% Feb 1, 2024
Dimitris Voliotis SVP, Clinical Development $1.32M Feb 10, 2022
Carrie Brownstein Chief Medical Officer $1.09M -$207K -16% Oct 4, 2023
Jan Skvarka Director $1.07M Jun 21, 2024
Enoch Kariuki Director $956K Jun 21, 2024
Luke Nathaniel Walker Director $915K May 24, 2024
Vincent Vultaggio Principal Accounting Officer $406K Apr 5, 2024

Recent Insider Transactions by Companies or Individuals for Zentalis Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.